See Announcement "08/01/2008 Patents for Treatment of Alzheimer`s and Alcoholism"
"Although further specific trials are planned in Russia, the fact that Ropren has already been entered in the Russian Pharmacopoeia means that it can be used for these conditions at the discretion of the treating clinician as soon as it is available commercially. Dr Nina Petrovna Golovkina of the Skvortsova Stepanova Psychiatric Hospital has already indicated that her hospital would be using Ropren to treat alcoholics, drug addicts and patients with neurodegenerative disorders once it was available."
So Yes, it can and will be used for the treatment of Alzheimer's and Alcoholism as well as liver disease in Russia. Doesn't really matter though, we'll be supplied constrained for the indication of just liver disease anyway.
SLA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)